Ausgabe 9/2017
Inhalt (13 Artikel)
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Upendra P. Hegde, Bijay Mukherji
MuPeXI: prediction of neo-epitopes from tumor sequencing data
Anne-Mette Bjerregaard, Morten Nielsen, Sine Reker Hadrup, Zoltan Szallasi, Aron Charles Eklund
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity
Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi
FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapy
Simona Romano, Ester Simeone, Anna D’Angelillo, Paolo D’Arrigo, Michele Russo, Mario Capasso, Vito Alessandro Lasorsa, Nicola Zambrano, Paolo A. Ascierto, Maria Fiammetta Romano
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
Xizhi Wen, Ya Ding, Jingjing Li, Jingjing Zhao, Ruiqing Peng, Dandan Li, Baoyan Zhu, Yao Wang, Xing Zhang, Xiaoshi Zhang
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
Sanne Samuels, A. Marijne Heeren, Henry J. M. A. A. Zijlmans, Marij J. P. Welters, Joost H. van den Berg, Daisy Philips, Pia Kvistborg, Ilina Ehsan, Suzy M. E. Scholl, Bastiaan Nuijen, Ton N. M. Schumacher, Marc van Beurden, Ekaterina S. Jordanova, John B. A. G. Haanen, Sjoerd H. van der Burg, Gemma G. Kenter
KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
Nan Chen, Wenfeng Fang, Zhong Lin, Peijian Peng, Juan Wang, Jianhua Zhan, Shaodong Hong, Jiaxing Huang, Lin Liu, Jin Sheng, Ting Zhou, Ying Chen, Hongyu Zhang, Li Zhang
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma
Elisa Mazzoni, Silvia Pietrobon, Miriam Bilancia, Fabrizio Vinante, Antonella Rigo, Isacco Ferrarini, Antonio D’Agostino, Maria Vittoria Casali, Fernanda Martini, Mauro Tognon
Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma
Thilo Gambichler, Martha Gnielka, Ines Rüddel, Eggert Stockfleth, Markus Stücker, Lutz Schmitz
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner
Daniel W. Fowler, John Copier, Angus G. Dalgleish, Mark D. Bodman-Smith
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma
Roger Gilabert-Oriol, Sebastian G. B. Furness, Brett W. Stringer, Alexander Weng, Hendrik Fuchs, Bryan W. Day, Angela Kourakis, Andrew W. Boyd, David L. Hare, Mayank Thakur, Terrance G. Johns, Peter J. Wookey
Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model
Lei Zhang, Limin Wang, Khawar Ali Shahzad, Tao Xu, Xin Wan, Weiya Pei, Chuanlai Shen
Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2–4, 2016
Dolores Gallardo-Rincón, Juan Pablo Marquez, Esteban Celis